Pharmaceutical Sciences
12 articles · 2 journals
Journals in this subcategory (2)
-
Ocular Wafers as Next-Generation Ophthalmic Drug Delivery Systems: Design, Manufacturing, Recent Advances, and Clinical Translation
Gokulakrishnan Shanmugam, Durgadevi Muniyappan, Kaviya Kolanthagounder, Madhankumar Siva, Naveenya Murugesan, Praveen Kumar Lakshmanan, Kumbakonam Balachandhran Ilango
Pharma-X
· Pharmaceutical Sciences
· 2026-11-01
-
An economic evaluation of diazepam nasal spray (Valtoco®) for the treatment of seizure clusters/acute repetitive seizures in epilepsy patients
Sihan Li, Yashi Liu, Wanxin Chen, Yulin Ye, Peiyu Zhou, Jiahuan Ai, Jian Ming, Sheng Han
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-10-01
-
Progress and trends in novel drug R&D: Technological innovation, clinical breakthroughs, and industrial ecosystem restructuring
Jia Han, Shili Peng, Jianzhong Zhang, Xiunv Huang
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-10-01
-
Advances in Aceclofenac Delivery: Solubility Enhancement Strategies and Microneedle -Assisted Transdermal Drug Delivery
Gokulakrishnan Shanmugam, Lakshiya Priya Selvaraj, Anusha Prabhu, Dharshana Raja, Kavya Shree Venkatesan, Raghul Subramaniam, Kumbakonam Balachandran Ilango
Pharma-X
· Pharmaceutical Sciences
· 2026-10-01
-
A Reproducible Digital Pipeline for Semi-Automated Antibiotic Stewardship Surveillance from Routine Pharmacy Dispensing Data
Nining Suryani, Andi Muhammad Yagkin Padjalangi, Hasriadi Hasriadi
Pharma-X
· Pharmaceutical Sciences
· 2026-10-01
-
The minimum decision-relevant incremental QALY: A conceptual and methodological foundation for value-based decision making in HTA
Wen Li, Yun Bao, Ying Chen, Mengxia Yan, Kaijie Yao, Bin Wu
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-09-01
-
Refining a precision medicine economic evaluation framework: Insights from a multi-stakeholder consultative workshop
Dimple Butani, Yah Ru Juang, Laura Huey Mien Lim, Alec Morton, Jingmei Li, Jamaica Briones, Jing Lou, Naline Gandhi, Hwee-Lin Wee, Joanne Yuen Yie Ngeow, Kar Hui Ng, Namfon Sribundit, Nattiya Kapol, Chotika Suwanpanich, Parntip Juntama, Peh Joo Ho, Pritaporn Kingkaew, Sara Tasnim, Sharon Li Ting Pek, Thamonwan Dulsamphan, Tanainan Chuanchaiyakul, Vorasuk Shotelersuk, Wanrudee Isaranuwatchai, Yi Wang, Yue Zhang, Yot Teerawattananon, Wenjia Chen
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-09-01
-
Barriers and facilitators to accessing medicines in the UK: A qualitative study evaluating pharmaceutical industry perspectives
Nasir Abbas, Zaheer-Ud-Din Babar
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-09-01
-
Advances in online cost-effectiveness analysis models and AI-assisted decision support tools: A mixed-methods study with implications for China
Jiayi Zhang, Zehui Liu, Furong Tian, Yuqi Li, Yanjun Zhang, Yongbo Gao, Genyong Zuo
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-09-01
-
Health literacy as a driver of health outcomes and economic burden among patients visiting community pharmacies in Pakistan
Amjad Khan, Muhammad Asif, Saima Mushtaq, Sameen Abbas, Kiran Hameed, Arslan Khan, Yalin Dong, Weiyi Feng, Yu Fang
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-09-01
-
Cost-utility of injectable and oral GLP-1RAs for type 2 diabetes mellitus inadequately controlled with metformin: A Markov model analysis
Penglin Zhou, Rui Gao, Anan Li, Xichao Wu, Yanjiao Zhu, Shuai He, Yan Li, Rui Yang
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-09-01
-
Predictors of complementary and alternative medicine use and its association with attitudes toward antiviral therapy among patients with hepatitis C in Pakistan: A cross-sectional study
Fatima Zahoor, Asim. ur. Rehman, Sundus Shukar, Naveed Ahmed, Kalsoom Saleem, Ayesha Bibi, Faiz Ullah Khan
Pharmacoeconomics and Policy
· Pharmaceutical Sciences
· 2026-09-01